Apparently, Soliris drug sales are increasing. https://alphastreet.com/bite/4dac307 But how long can this company run on this? Given, the company has also announced that it is reducing the R&D expense for the year.
R&D is pretty much gutted, I don't know this but I would guess they are positioning for a sale (no pipeline is pretty much death in biotech).